首页> 外文会议>Falk Symposium >How to deal with dysplasia and adenomatous polyps in inflammatory bowel disease
【24h】

How to deal with dysplasia and adenomatous polyps in inflammatory bowel disease

机译:如何应对炎症性肠病的发育不良和腺瘤息肉

获取原文

摘要

It is well recognized that carcinoma of the colon is the major complication in patients with long-standing inflammatory bowel disease (IBD). The first report of a rectal carcinoma arising in long-standing ulcerative colitis (UQ was from Crohn and Rosenberg in 19251. After this first report, numerous other reports established the clinical and morphological features observed in UC undergoing malignant change. In 1949 Warren and Sommers2 analysed the pathogenesis of UC and sustained the concept of a 'precancerous epithelial hyperplasia' stage. Morson and Pang3 in 1967 proposed the use of rectal biopsy in the surveillance and diagnosis of cancer in UC patients. Despite the general agreement that extensive and long-standing disease predisposes to the development of colorectal neoplasia, the recognition and grading of the first steps of the neoplastic process have been a controversial issue. The concept of dysplasia as a premalignant lesion was then developed in the context of IBD and remains the gold standard to identify high-risk patients.
机译:众所周知,结肠癌癌是长期炎症性肠病(IBD)的主要并发症。长期溃疡性结肠炎(UQ来自Crohn和Rosenberg的第一份报告,19251年。在第一次报告之后,许多其他报告确定了在植物中观察到的临床和形态特征,正在进行恶性变化。1949年沃伦和索姆瑟尔2分析了UC的发病机制,持续了“癌前上皮增生”阶段的概念。Morson和Pang3在1967年提出了直肠活检在UC患者癌症的监测和诊断中。尽管普遍同意广泛和长期疾病易于发展结直肠瘤形成,肿瘤过程的第一步的识别和分级是一个有争议的问题。然后在IBD的背景下制定了作为预血生病变的发育不良的概念,仍然是识别的黄金标准高风险患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号